Affiliation:
1. SİİRT ÜNİVERSİTESİ, TIP FAKÜLTESİ
2. SİİRT ÜNİVERSİTESİ
3. Erzincan Binali Yıldırım Üniversitesi Tıp Fakültesi
Abstract
Abstract: In this study, it was aimed to show the efficacy of intravenous (IV) ferric carboxymaltose treatment for iron deficiency anemia (IDA), which is a public health problem due to its high prevalence in the world and in Turkey. Since it is the first study in the region, its importance is increasing even more. Eighty female diagnosed with IDA and treated with IV iron carboxymaltose, who applied to Siirt Training and Research Hospital Internal Diseases Polyclinics between June 2018 and September 2019, were included in the study. After obtaining voluntary consent of female patients, biochemical data of pre- and post-treatment were included in the study retrospectively. After treatment, hemoglobin (HGB), hematocrit (HTC), mean cell volume (MCV), ferritin, iron and B12 values increased statistically (p
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference29 articles.
1. Bainton DF, Finch CA. The diagnosis of iron deficiency anemia. Am J Med, 1967;37:62-69.
2. DeMaeyer E, Adiels-Tegman M. The prevelance of anemia in the world. World Health Stat Q 1985;38:302-306.
3. Frewin R, Henson A, Provan D. Iron deficiency anemia. BMJ 1997;314:360-363.
4. T.C. Sağlık Bakanlığı, Anne Çocuk Sağlığı Genel Müdürlüğü. 12- 23 aylık çocuklarda demir kullanımı araştırması raporu, Ankara; 2008.
5. Danielson BG, Geisser P, Schneider W. [eds]. Iron therapy with special emphasis on intravenous administration. 1st ed. St. Gallen, Switzerland: Vifor (International) Inc; 1996.